Alternatives to Coltac Therapeutics

Developing novel therapeutics for cancer by targeting the tumor microenvironment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Develops a platform for adaptive clinical trial design and closed-loop execution.